{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T01:03:00Z","timestamp":1775091780174,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI1096159"],"award-info":[{"award-number":["R01AI1096159"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Monoclonal antibodies (mAbs) play an important role in diagnostics and therapy of infectious diseases. Here we utilize a single-particle interferometric reflectance imaging sensor (SP-IRIS) for screening 30 mAbs against Ebola, Sudan, and Lassa viruses (EBOV, SUDV, and LASV) to find out the ideal capture antibodies for whole virus detection using recombinant vesicular stomatitis virus (rVSV) models expressing surface glycoproteins (GPs) of EBOV, SUDV, and LASV. We also make use of the binding properties on SP-IRIS to develop a model for mapping the antibody epitopes on the GP structure. mAbs that bind to mucin-like domain or glycan cap of the EBOV surface GP show the highest signal on SP-IRIS, followed by mAbs that target the GP1-GP2 interface at the base domain. These antibodies were shown to be highly efficacious against EBOV infection in non-human primates in previous studies. For LASV detection, 8.9F antibody showed the best performance on SP-IRIS. This antibody binds to a unique region on the surface GP compared to other 15 mAbs tested. In addition, we demonstrate a novel antibody competition assay using SP-IRIS and rVSV-EBOV models to reveal the competition between mAbs in three successful therapeutic mAb cocktails against EBOV infection. We provide an explanation as to why ZMapp cocktail has higher efficacy compared to the other two cocktails by showing that three mAbs in this cocktail (13C6, 2G4, 4G7) do not compete with each other for binding to EBOV GP. In fact, the binding of 13C6 enhances the binding of 2G4 and 4G7 antibodies. Our results establish SP-IRIS as a versatile tool that can provide high-throughput screening of mAbs, multiplexed and sensitive detection of viruses, and evaluation of therapeutic antibody cocktails.<\/jats:p>","DOI":"10.1038\/s41598-022-27281-w","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T10:05:10Z","timestamp":1672999510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A high-throughput single-particle imaging platform for antibody characterization and a novel competition assay for therapeutic antibodies"],"prefix":"10.1038","volume":"13","author":[{"given":"Elif","family":"Seymour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Selim","family":"\u00dcnl\u00fc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"key":"27281_CR1","unstructured":"COVID-19 Map\u2014 Johns Hopkins Coronavirus Resource Center. https:\/\/coronavirus.jhu.edu\/map.html. Accessed: 14th July 2022."},{"key":"27281_CR2","unstructured":"Multi-country monkeypox outbreak: situation update. https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2022-DON396. Accessed: 14 July 2022."},{"key":"27281_CR3","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.3390\/diagnostics11112083","volume":"11","author":"A Sharma","year":"2021","unstructured":"Sharma, A. et al. Optical biosensors for diagnostics of infectious viral disease: A recent update. Diagnostics 11, 2083 (2021).","journal-title":"Diagnostics"},{"key":"27281_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-824494-4.00017-5","author":"M Pal","year":"2022","unstructured":"Pal, M., Das, V., BoruahDeka, H. P. D. H. P. & Chikkaputtaiah, C. Multiplexed biosensors for virus detection. Adv. Biosens. Virus Detect. Smart Diagn. Combat SARS-CoV-2 https:\/\/doi.org\/10.1016\/B978-0-12-824494-4.00017-5 (2022).","journal-title":"Adv. Biosens. Virus Detect. Smart Diagn. Combat SARS-CoV-2"},{"key":"27281_CR5","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1021\/nl103210p","volume":"10","author":"GG Daaboul","year":"2010","unstructured":"Daaboul, G. G. et al. High-throughput detection and sizing of individual low-index nanoparticles and viruses for pathogen identification. Nano Lett. 10, 4727\u20134731 (2010).","journal-title":"Nano Lett."},{"key":"27281_CR6","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.1021\/nn501312q","volume":"8","author":"GG Daaboul","year":"2014","unstructured":"Daaboul, G. G. et al. Digital sensing and sizing of vesicular stomatitis virus pseudotypes in complex media: A model for ebola and marburg detection. ACS Nano 8, 6047\u20136055 (2014).","journal-title":"ACS Nano"},{"key":"27281_CR7","doi-asserted-by":"publisher","first-page":"17649","DOI":"10.3390\/s150717649","volume":"15","author":"O Avci","year":"2015","unstructured":"Avci, O., \u00dcnl\u00fc, N. L., \u00d6zkumur, A. Y. & \u00dcnl\u00fc, M. S. Interferometric reflectance imaging sensor (IRIS)\u2014A platform technology for multiplexed diagnostics and digital detection. Sensors (Switzerland) 15, 17649\u201317665 (2015).","journal-title":"Sensors (Switzerland)"},{"key":"27281_CR8","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1021\/ac4000514","volume":"85","author":"MR Monroe","year":"2013","unstructured":"Monroe, M. R. et al. Single nanoparticle detection for multiplexed protein diagnostics with attomolar sensitivity in serum and unprocessed whole blood. Anal. Chem. 85, 3698\u20133706 (2013).","journal-title":"Anal. Chem."},{"key":"27281_CR9","doi-asserted-by":"publisher","first-page":"6836","DOI":"10.1021\/acsomega.0c05994","volume":"6","author":"AM Marn","year":"2021","unstructured":"Marn, A. M., Chiodi, E. & \u00dcnl\u00fc, M. S. Bulk-effect-free method for binding kinetic measurements enabling small-molecule affinity characterization. ACS Omega 6, 6836\u20136841 (2021).","journal-title":"ACS Omega"},{"key":"27281_CR10","doi-asserted-by":"publisher","first-page":"18197","DOI":"10.1364\/OE.24.018197","volume":"24","author":"X Zhou","year":"2016","unstructured":"Zhou, X., Zhang, L. & Pang, W. Performance and noise analysis of optical microresonator-based biochemical sensors using intensity detection. Opt. Express 24, 18197\u201318208 (2016).","journal-title":"Opt. Express"},{"key":"27281_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nbt1388","volume":"26","author":"TM Squires","year":"2008","unstructured":"Squires, T. M., Messinger, R. J. & Manalis, S. R. Making it stick: Convection, reaction and diffusion in surface-based biosensors. Nat. Biotechnol. 26, 417\u2013426 (2008).","journal-title":"Nat. Biotechnol."},{"key":"27281_CR12","doi-asserted-by":"publisher","first-page":"37246","DOI":"10.1038\/srep37246","volume":"6","author":"GG Daaboul","year":"2016","unstructured":"Daaboul, G. G. et al. Digital detection of exosomes by interferometric imaging. Sci. Rep. 6, 37246 (2016).","journal-title":"Sci. Rep."},{"key":"27281_CR13","doi-asserted-by":"publisher","first-page":"16220","DOI":"10.1038\/s41598-022-19912-z","volume":"12","author":"F EkizKanik","year":"2022","unstructured":"EkizKanik, F. et al. Attomolar sensitivity microRNA detection using real-time digital microarrays. Sci. Rep. 12, 16220 (2022).","journal-title":"Sci. Rep."},{"key":"27281_CR14","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1073\/pnas.1815329116","volume":"116","author":"D Sevenler","year":"2019","unstructured":"Sevenler, D., Trueb, J. & Selim\u00dcnl\u00fc, M. Beating the reaction limits of biosensor sensitivity with dynamic tracking of single binding events. Proc. Natl. Acad. Sci. U. S. A. 116, 4129\u20134134 (2019).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"27281_CR15","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1021\/acsnano.5b07948","volume":"10","author":"SM Scherr","year":"2016","unstructured":"Scherr, S. M. et al. Real-time capture and visualization of individual viruses in complex media. ACS Nano 10, 2827\u20132833 (2016).","journal-title":"ACS Nano"},{"key":"27281_CR16","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1039\/C6LC01528J","volume":"17","author":"SM Scherr","year":"2017","unstructured":"Scherr, S. M. et al. Disposable cartridge platform for rapid detection of viral hemorrhagic fever viruses. Lab Chip 17, 917\u2013925 (2017).","journal-title":"Lab Chip"},{"key":"27281_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1021\/acssensors.0c02203","volume":"6","author":"E Seymour","year":"2021","unstructured":"Seymour, E., \u00dcnl\u00fc, N. L., Carter, E. P., Connor, J. H. & \u00dcnl\u00fc, M. S. Configurable digital virus counter on robust universal DNA chips. ACS Sensors 6, 229\u2013237 (2021).","journal-title":"ACS Sensors"},{"key":"27281_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41541-017-0019-3","volume":"2","author":"G Salazar","year":"2017","unstructured":"Salazar, G., Zhang, N., Fu, T.-M. & An, Z. Antibody therapies for the prevention and treatment of viral infections. npj Vaccines 2, 19 (2017).","journal-title":"npj Vaccines"},{"key":"27281_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jconrel.2020.11.057","volume":"329","author":"SK Lai","year":"2021","unstructured":"Lai, S. K., McSweeney, M. D. & Pickles, R. J. Learning from past failures: Challenges with monoclonal antibody therapies for COVID-19. J. Control. Release 329, 87\u201395 (2021).","journal-title":"J. Control. Release"},{"key":"27281_CR20","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.1128\/JVI.73.7.6024-6030.1999","volume":"73","author":"T Maruyama","year":"1999","unstructured":"Maruyama, T. et al. Ebola virus can be effectively neutralized by antibody produced in natural human infection. J. Virol. 73, 6024\u20136030 (1999).","journal-title":"J. Virol."},{"key":"27281_CR21","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1126\/science.287.5458.1664","volume":"287","author":"JA Wilson","year":"2000","unstructured":"Wilson, J. A. et al. Epitopes involved in antibody-mediated protection from Ebola virus. Science 287, 1664\u20131666 (2000).","journal-title":"Science"},{"key":"27281_CR22","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.vaccine.2006.09.076","volume":"25","author":"A Takada","year":"2007","unstructured":"Takada, A., Ebihara, H., Jones, S., Feldmann, H. & Kawaoka, Y. Protective efficacy of neutralizing antibodies against Ebola virus infection. Vaccine 25, 993\u2013999 (2007).","journal-title":"Vaccine"},{"key":"27281_CR23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.clim.2011.08.008","volume":"141","author":"X Qiu","year":"2011","unstructured":"Qiu, X. et al. Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies. Clin. Immunol. 141, 218\u2013227 (2011).","journal-title":"Clin. Immunol."},{"key":"27281_CR24","unstructured":"Oswald_2007_KZ52_failure_in_NHPs.pdf."},{"key":"27281_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0036192","volume":"7","author":"A Marzi","year":"2012","unstructured":"Marzi, A. et al. Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of ebola hemorrhagic fever. PLoS ONE 7, 1\u20137 (2012).","journal-title":"PLoS ONE"},{"key":"27281_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1371\/journal.pntd.0001575","volume":"6","author":"X Qiu","year":"2012","unstructured":"Qiu, X. et al. Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection. PLoS Negl. Trop. Dis. 6, 31\u201334 (2012).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"27281_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.3003876","volume":"4","author":"X Qiu","year":"2012","unstructured":"Qiu, X. et al. Successful treatment of Ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci. Transl. Med. 4, 1\u201312 (2012).","journal-title":"Sci. Transl. Med."},{"key":"27281_CR28","doi-asserted-by":"publisher","first-page":"18030","DOI":"10.1073\/pnas.1213709109","volume":"109","author":"GG Olinger","year":"2012","unstructured":"Olinger, G. G. et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc. Natl. Acad. Sci. U. S. A. 109, 18030\u201318035 (2012).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"27281_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006608","author":"J Pettitt","year":"2013","unstructured":"Pettitt, J. et al. Therapeutic intervention of ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.3006608 (2013).","journal-title":"Sci. Transl. Med."},{"key":"27281_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature13777","volume":"514","author":"X Qiu","year":"2014","unstructured":"Qiu, X. et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514, 47\u201353 (2014).","journal-title":"Nature"},{"key":"27281_CR31","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1056\/NEJMoa1604330","volume":"375","author":"A Randomized","year":"2016","unstructured":"Randomized, A. Controlled trial of ZMapp for ebola virus infection. N. Engl. J. Med. 375, 1448\u20131456 (2016).","journal-title":"N. Engl. J. Med."},{"key":"27281_CR32","doi-asserted-by":"publisher","first-page":"17182","DOI":"10.1073\/pnas.1414164111","volume":"111","author":"CD Murin","year":"2014","unstructured":"Murin, C. D. et al. Structures of protective antibodies reveal sites of vulnerability on ebola virus. Proc. Natl. Acad. Sci. U. S. A. 111, 17182\u201317187 (2014).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"27281_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ab.2004.05.041","volume":"332","author":"M Cretich","year":"2004","unstructured":"Cretich, M., Pirri, G., Damin, F., Solinas, I. & Chiari, M. A new polymeric coating for protein microarrays. Anal. Biochem. 332, 67\u201374 (2004).","journal-title":"Anal. Biochem."},{"key":"27281_CR34","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1021\/ac0352629","volume":"76","author":"G Pirri","year":"2004","unstructured":"Pirri, G., Damin, F., Chiari, M., Bontempi, E. & Depero, L. E. Characterization of a polymeric adsorbed coating for DNA microarray glass slides. Anal. Chem. 76, 1352\u20131358 (2004).","journal-title":"Anal. Chem."},{"key":"27281_CR35","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1109\/JSTQE.2016.2639824","volume":"23","author":"JT Trueb","year":"2017","unstructured":"Trueb, J. T., Avci, O., Sevenler, D., Connor, J. H. & \u00dcnl\u00fc, M. S. Robust Visualization and Discrimination of Nanoparticles by Interferometric Imaging. IEEE J. Sel. Top. Quantum Electron. 23, 394\u2013403 (2017).","journal-title":"IEEE J. Sel. Top. Quantum Electron."},{"key":"27281_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv126","author":"CE Mire","year":"2015","unstructured":"Mire, C. E. et al. A single-vector, single-injection trivalent filovirus vaccine: Proof of concept study in outbred guinea pigs. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiv126 (2015).","journal-title":"J. Infect. Dis."},{"key":"27281_CR37","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.virol.2010.02.029","volume":"401","author":"DJ Shedlock","year":"2010","unstructured":"Shedlock, D. J. et al. Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms. Virology 401, 228\u2013235 (2010).","journal-title":"Virology"},{"issue":"1","key":"27281_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep25856","volume":"6","author":"Q Zhang","year":"2016","unstructured":"Zhang, Q. et al. Potent neutralizing monoclonal antibodies against Ebola virus infection. Nat. Publ. Gr. 6(1), 1\u201315. https:\/\/doi.org\/10.1038\/srep25856 (2016).","journal-title":"Nat. Publ. Gr."},{"key":"27281_CR39","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jviromet.2006.06.014","volume":"137","author":"JS Yu","year":"2006","unstructured":"Yu, J. S. et al. Detection of Ebola virus envelope using monoclonal and polyclonal antibodies in ELISA, surface plasmon resonance and a quartz crystal microbalance immunosensor. J. Virol. Methods 137, 219\u2013228 (2006).","journal-title":"J. Virol. Methods"},{"key":"27281_CR40","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41564-018-0157-z","volume":"3","author":"AI Flyak","year":"2018","unstructured":"Flyak, A. I. et al. Broadly neutralizing antibodies from human survivors target a conserved site in the ebola virus glycoprotein hr2-mper region. Nat. Microbiol. 3, 670\u2013677 (2018).","journal-title":"Nat. Microbiol."},{"key":"27281_CR41","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/imm.12284","volume":"142","author":"WM Abbott","year":"2014","unstructured":"Abbott, W. M., Damschroder, M. M. & Lowe, D. C. Current approaches to fine mapping of antigen-antibody interactions. Immunology 142, 526\u2013535 (2014).","journal-title":"Immunology"},{"key":"27281_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ddtec.2020.12.003","volume":"38","author":"C Wigge","year":"2020","unstructured":"Wigge, C., Stefanovic, A. & Radjainia, M. The rapidly evolving role of cryo-EM in drug design. Drug Discov. Today Technol. 38, 91\u2013102 (2020).","journal-title":"Drug Discov. Today Technol."},{"key":"27281_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-7841-0_1","volume-title":"Epitope Mapping Protocols","author":"J Nilvebrant","year":"2018","unstructured":"Nilvebrant, J. & Rockberg, J. An introduction to epitope mapping. In Epitope Mapping Protocols (eds Rockberg, J. & Nilvebrant, J.) 1\u201310 (Springer, 2018). https:\/\/doi.org\/10.1007\/978-1-4939-7841-0_1."},{"key":"27281_CR44","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nrd.2018.77","volume":"17","author":"JP Renaud","year":"2018","unstructured":"Renaud, J. P. et al. Cryo-EM in drug discovery: Achievements, limitations and prospects. Nat. Rev. Drug Discov. 17, 471\u2013492 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"27281_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/mas.21516","volume":"37","author":"KFM Opuni","year":"2018","unstructured":"Opuni, K. F. M. et al. Mass spectrometric epitope mapping. Mass Spectrom. Rev. 37, 229\u2013241 (2018).","journal-title":"Mass Spectrom. Rev."},{"key":"27281_CR46","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1021\/jasms.0c00341","volume":"32","author":"MJ Watson","year":"2021","unstructured":"Watson, M. J. et al. Simple platform for automating decoupled LC-MS analysis of hydrogen\/deuterium exchange samples. J. Am. Soc. Mass Spectrom. 32, 597\u2013600 (2021).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"27281_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/life10110286","volume":"10","author":"O Ozohanics","year":"2020","unstructured":"Ozohanics, O. & Ambrus, A. Hydrogen-deuterium exchange mass spectrometry: A novel structural biology approach to structure, dynamics and interactions of proteins and their complexes. Life 10, 1\u201318 (2020).","journal-title":"Life"},{"key":"27281_CR48","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/978-1-62703-992-5_27","volume-title":"Monoclonal Antibodies: Methods and Protocols","author":"G Rojas","year":"2014","unstructured":"Rojas, G. Fine epitope mapping based on phage display and extensive mutagenesis of the target antigen. In Monoclonal Antibodies: Methods and Protocols (eds Ossipow, V. & Fischer, N.) 447\u2013476 (Humana Press, 2014). https:\/\/doi.org\/10.1007\/978-1-62703-992-5_27."},{"key":"27281_CR49","doi-asserted-by":"publisher","first-page":"11544","DOI":"10.1038\/ncomms11544","volume":"7","author":"JE Robinson","year":"2016","unstructured":"Robinson, J. E. et al. Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits. Nat. Commun. 7, 11544  (2016).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27281-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27281-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27281-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T10:09:55Z","timestamp":1672999795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27281-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["27281"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-27281-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1898923\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"assertion":[{"value":"26 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"306"}}